Extended Data Table 2.
Responses to tovorafenib in patients on a MAPKi as their most recent prior therapy and discontinued due to progression*
*Note: RAPNO-LGG and RANO-LGG endpoints include MR.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.